Posted On: 05/03/2016 5:21:30 PM
Post# of 72447
In the real world, would Dana-Farber have submitted a paper on Kevetrin for publication in a peer-reviewed journal, if the results were bad?
"Hey everyone, here's my study that failed, publish it."
Of course not.
There are so many indications of possible success. I simply can't conceive of the idea that 3 drugs, for 4 (and soon to be 5) different indications, would ALL fail. Success for any one of those indications would put the share price far higher than it is now.
"Hey everyone, here's my study that failed, publish it."
Of course not.
There are so many indications of possible success. I simply can't conceive of the idea that 3 drugs, for 4 (and soon to be 5) different indications, would ALL fail. Success for any one of those indications would put the share price far higher than it is now.
(0)
(0)
